Vipul H. Shah, MD, FACP

I see patients at the following locations:

Education

Bachelor’s Degree – Rutgers University

Medical Degree – UMDNJ/Rutgers Medical School

Internship – New York Presbyterian/Columbia University

Residency – New York Presbyterian/Columbia University

Fellowship – New York Presbyterian/Columbia University

Board Certifications – Gastroenterology, Internal Medicine

Honors & Awards

  • NYSGE Fellow Award/ David B. Falkenstein Scholarship Award
  • Castle Connolly Top Doctors, 2017-present

Specialties & Main Areas of Interest

  • Colon Cancer Screening
  • Endoscopic Ultrasound (EUS)
  • Gastroesophageal Reflux Disease (GERD)
  • Interventional GI
  • Pancreatic/Biliary Disease
  • Liver Disease

Hospital Affiliations

  • Good Samaritan
  • Montefiore Nyack Hospital

Other Appointments

  • Vice President Medical Staff, Good Samaritan Hospital
  • Co-Director Reflux Center, Good Samaritan Hospital
  • Previous Chief of Gastroenterology, Nyack Hospital

Research

  • 12 week randomized double blind, placebo controlled study of the efficacy and tolerability of Alosetron HC lmg BID for the control of bowel urgency in females with nonconstipated JBS in and independent practioner association model. Protocol #S3B40051. 2000
  • START: Standard Therapeutic Assessment of Rebetron Trial. Indiana University Indiana.
  • A Comparative Efficacy Study of Esomeprazole and Lansoprazole in patients with Erosive Esophagitis.Protocol #267. 2000
  • Roche Labs, Inc. Prospective randomize multicenter open label comparative safety study of Pegasys vs Pegasys plus ribavarin in treatment of patients with Hep C “Wings Trial” May 2001
  • Proctor and Gamble. Asacol 4.8gm/day vs. 2.4gm/day in mild to moderate ulcerative colitis patients experiencing an active flare. March 200I
  • Abbott Labs. Multi Center randomized double blind, placebo controlled study of Human Anti-TNF Monoclonal antibody Adalimurnab for the induction and maintenance of clinical remission in subjects with Crohn’s disease. April 2003
  • GlaxoSmithKline. A 12 week randomized double blinded placebo controlled study of PRN BID and fixed dosing regimens of alosetron in female subjects with severe diarrhea-predominant irritable bowel syndrome who have failed conventional therapy. September 2003.

Fun Facts

  • In his spare time, Dr. Shah enjoys playing tennis.

Important Notice: Participating Carriers

We are pleased to inform you that our services are covered by a variety of participating insurance carriers. Please review the list of participating carriers to ensure your plan is included.